Actively Recruiting
28-day Mortality Prediction for Critically Ill Patients in the Intensive Care Unit: Physician-nurse vs. Score. A Prospective Observational Study
Led by Meir Medical Center · Updated on 2025-05-13
2000
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating how well experienced intensive care unit (ICU) physicians and nurses can predict patient mortality within 28 days compared to three established scoring models: APACHE 2, MPM 2, and MODS. This study aims to determine whether medical staff predictions are as accurate or better than these models, which are used to guide ICU admission and care management decisions. It also explores which factors most influence the predictions made by ICU staff. This research is a prospective observational study involving about 2,000 patients admitted to the ICU between 2025 and 2027. For each patient, mortality risk will be calculated using the three scoring systems, while three senior ICU physicians and one experienced ICU nurse independently estimate the risk based on their clinical judgment. The reasons behind the medical and nursing staff's mortality risk assessments will also be documented. Participants will be monitored during their ICU stay, with mortality predictions recorded and compared over a 28-day period. The study measures how accurately ICU staff and scoring systems predict mortality, helping to assess the reliability of clinical judgment versus model-based scores. The findings may inform future ICU care strategies and patient management. The study is sponsored by Meir Medical Center and does not involve any intervention or treatment changes for participants.
CONDITIONS
Brief Title
28-day Mortality Prediction for Critically Ill Patients in the Intensive Care Unit: Physician-nurse vs. Score
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients admitted to the ICU between 1.1.2025 and 1.1.2027
You will not qualify if you...
- Patients who were hospitalized in the ICU for less than 72 hours
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 72 hours
Participants admitted to the ICU are assessed by ICU staff using clinical judgment and mortality scoring systems.
Assessment during ICU stay
Duration - 28 days
Participants are monitored for 28-day mortality outcomes following ICU admission.
Monitoring over 28 days
Trial Site Locations
Total: 1 location
1
Meir Medical Center
Kfar Saba, Israel
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here